Entero Healthcare Solutions Limited (NSE:ENTERO)

India flag India · Delayed Price · Currency is INR
996.40
-10.30 (-1.02%)
At close: Dec 12, 2025
-32.07%
Market Cap43.80B
Revenue (ttm)56.73B
Net Income (ttm)1.11B
Shares Out43.51M
EPS (ttm)25.36
PE Ratio39.70
Forward PE26.03
Dividendn/a
Ex-Dividend Daten/a
Volume122,118
Average Volume79,398
Open1,006.50
Previous Close1,006.70
Day's Range977.90 - 1,018.80
52-Week Range987.60 - 1,563.90
Betan/a
RSI34.78
Earnings DateFeb 14, 2026

About NSE:ENTERO

Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also provides nebulizers, personal protective, hygiene and surgical consumable products, homecare medical devices, gloves and mobility equipment, digital the... [Read more]

Sector Healthcare
Founded 2018
Employees 4,111
Stock Exchange National Stock Exchange of India
Ticker Symbol ENTERO
Full Company Profile

Financial Performance

In 2024, NSE:ENTERO's revenue was 50.96 billion, an increase of 29.92% compared to the previous year's 39.22 billion. Earnings were 948.20 million, an increase of 142.45%.

Financial Statements

News

Entero Healthcare Solutions Ltd (NSE:ENTERO) Q2 2026 Earnings Call Highlights: Strong Revenue ...

Entero Healthcare Solutions Ltd (NSE:ENTERO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid Acquisition Expansion

4 weeks ago - GuruFocus

Q2 2026 Entero Healthcare Solutions Ltd Earnings Call Transcript

Q2 2026 Entero Healthcare Solutions Ltd Earnings Call Transcript

4 weeks ago - GuruFocus